Lotus Pharmaceutical Co., Ltd.(TW:1795)
NT$166.50+0.00 (+0.30%)
TW:1795
Lotus Pharmaceutical Co., Ltd. ownership
NT$166.50
At close:+0.00 (+0.30%)
Lotus Pharmaceutical Co., Ltd. (1795) Ownership - Who Owns Lotus Pharmaceutical Co., Ltd.?
Lotus Pharmaceutical Co., Ltd. (1795) Ownership Overview
- 3.16% ETFs
- 96.84% Public Companies and Individual Investors
The ownership structure of Lotus Pharmaceutical Co., Ltd. (TW:1795) stock is a mix of institutional, retail, and individual investors. Approximately 3.16% of the company’s stock is owned by Institutional Investors, and 96.84% is owned by Public Companies and Individual Investors.
The ownership structure of Lotus Pharmaceutical Co., Ltd. (TW:1795) stock is a mix of institutional, retail, and individual investors. Approximately 3.16% of the company’s stock is owned by Institutional Investors, and 96.84% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 4,632,539 | Institution | 1.72% | 23,347,997 |
| Ishares | 3,154,523 | Institution | 1.17% | 15,898,796 |
| Avantis | 270,032 | Institution | 0.10% | 1,360,961 |
| Dimensional | 147,405 | Institution | 0.05% | 742,921 |
| Wisdomtree | 146,845 | Institution | 0.05% | 740,099 |
| State Street | 97,430 | Institution | 0.04% | 491,047 |
| Spdr | 64,832 | Institution | 0.02% | 326,753 |
| Hsbc | 8,226 | Institution | <0.01% | 41,459 |
| Northern Trust | 2,026 | Institution | <0.01% | 10,211 |
| Ci | 1,769 | Institution | <0.01% | 8,916 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard, VXUS ETF | 2,017,087 | Institution | 0.75% | 11,316,523 |
| Vanguard, VWO ETF | 1,937,270 | Institution | 0.72% | 10,868,723 |
| iShares, IEMG ETF | 1,609,666 | Institution | 0.60% | 8,215,903 |
| Vanguard, VSS ETF | 517,023 | Institution | 0.19% | 2,900,669 |
| iShares, IXUS ETF | 222,861 | Institution | 0.08% | 1,137,506 |
| Avantis, AVEM ETF | 216,628 | Institution | 0.08% | 1,064,736 |
| WisdomTree, DGS ETF | 144,859 | Institution | 0.05% | 735,100 |
| Vanguard, VT ETF | 123,586 | Institution | 0.05% | 693,358 |
| iShares, GB:SEDM ETF | 83,066 | Institution | 0.03% | 424,070 |
| State Street, EWX ETF | 67,040 | Institution | 0.02% | 342,254 |
FAQ
What percentage of Lotus Pharmaceutical Co., Ltd. (TW:1795) stock is held by institutional investors?
According to the latest TipRanks data, approximately 3.16% of Lotus Pharmaceutical Co., Ltd. (TW:1795) stock is held by institutional investors.
What percentage of Lotus Pharmaceutical Co., Ltd. (TW:1795) stock is held by retail investors?
According to the latest TipRanks data, approximately 96.84% of Lotus Pharmaceutical Co., Ltd. (TW:1795) stock is held by public companies and individual investors.
Who owns the most shares of Lotus Pharmaceutical Co., Ltd. (TW:1795)?
Vanguard owns the most shares of Lotus Pharmaceutical Co., Ltd. (TW:1795).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
